Advertisement
Research Article| Volume 7, ISSUE 5, P393-395, 2005

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

      The plastic-adherent cells isolated from BM and other sources have come to be widely known as mesenchymal stem cells (MSC). However, the recognized biologic properties of the unfractionated population of cells do not seem to meet generally accepted criteria for stem cell activity, rendering the name scientifically inaccurate and potentially misleading to the lay public. Nonetheless, a bona fide MSC most certainly exists. To address this inconsistency between nomenclature and biologic properties, and to clarify the terminology, we suggest that the fibroblast-like plastic-adherent cells, regardless of the tissue from which they are isolated, be termed multipotent mesenchymal stromal cells, while the term mesenchymal stem cells is used only for cells that meet specified stem cell criteria. The widely recognized acronym, MSC, may be used for both cell populations, as is the current practice; thus, investigators must clearly define the more scientifically correct designation in their reports. The International Society for Cellular Therapy (ISCT) encourages the scientific community to adopt this uniform nomenclature in all written and oral communications.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Owen M.
        Lineage of osteogenic cells and their relationship to the stromal system.
        in: Peck W. Bone and Mineral Research. Elsevier, New York1985: 1-25
        • Owen M.
        Marrow stromal stem cells.
        J Cell Sci. 1988; 10: 63-76
        • Friedenstein A.J.
        • Petrakova K.V.
        • Kurolesova A.I.
        • et al.
        Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.
        Transplantation. 1968; 6: 230-247
        • Friedenstein A.J.
        • Chailakhyan R.K.
        • Latsinik N.V.
        • et al.
        Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo.
        Transplantation. 1974; 17: 331-340
        • Caplan A.I.
        Mesenchymal stem cells.
        J Orthop Res. 1991; 9: 641-650
        • Pereira R.F.
        • Halford K.W.
        • O'Hara M.D.
        • et al.
        Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.
        Proc Natl Acad Sci USA. 1995; 92: 4857-4861
        • Pereira R.F.
        • O'Hara M.D.
        • Laptev A.
        • et al.
        Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.
        Proc Natl Acad Sci USA. 1998; 95: 1142-1147
        • Keating A.
        • Berkahn L.
        • Filshie R.
        A phase I study of the transplantation of genetically marked autologous bone marrow stromal cells.
        Hum Gene Ther. 1998; 9: 591-600
        • Horwitz E.M.
        • Prockop D.J.
        • Fitzpatrick L.A.
        • et al.
        Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.
        Nat Med. 1999; 5: 309-313
        • Horwitz E.M.
        • Gordon P.L.
        • Koo W.K.K.
        • et al.
        Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone.
        Proc Natl Acad Sci USA. 2002; 99: 8932-8937
        • Horwitz E.M.
        • Keating A.
        Nonhematopoietic mesenchymal stem cells: what are they?.
        Cytotherapy. 2000; 2: 387-388